NSEInvestor Presentation1d ago · 17 Nov 2026, 05:55 pm
Investor Presentation
IIRM Holdings India Limited · IIRM
✦ AI SummaryResults
IIRM Holdings India Limited has informed the Exchange about Investor Presentation for Q2 FY27 (6M- FY 27) with attached presentation available on the company's website.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
IIRM Holdings India Limited has informed the Exchange about Investor Presentation
Attachments (1)
📄pdf
Download →
8447772518_17112026175455_Investor_Presentation_Q2_FY27_SD.pdf
View document text
Date: 17/11/2026
BSE Limited, National Stock Exchange of India Limited The Calcutta Stock Exchange Limited
1st Floor, P.J. Towers, Exchange Plaza, Plot No. C/1, G Block, 7, Lyons Range,
Dalal Street, Fort, Bandra-Kurla Complex, Dalhousie,
Mumbai - 400 001. Bandra (East), Mumbai 400051 Kolkata 700 001
Scrip Code: 526530 Scrip Code: IIRM Scrip Code: 029404
Subject: Investor Presentation – Q2 FY27 (6M- FY 27)
Respected Sir/Madam,
With reference to above captioned subject, please find attached herewith Investor Presentation – Q2
FY27. (6M- FY 27)
This intimation is also being made available on the website of the Company at
https://www.iirmholdings.in/investor/other-information-disclosures/.
Kindly take the above information on record.
Thanking You.
Yours faithfully,
For IIRM Holdings India Limited
Vempala Sri Lakshmi
Company Secretary & Compliance Officer
M. No. F9950
Your Trusted Partner in Global Insurance Solutions
I nv estor P resentati on Q 2- F Y 27
Safe Harbour
This presentation has been prepared by and is the sole responsibility of IIRM Holdings India Limited (the “Company”). By accessing
this presentation, you are agreeing to be bound by the trailing restrictions.
This presentation does not constitute or form part of any offer or invitation or inducement to sell or issue, or any solicitation of any
offer or recommendation to purchase or subscribe for, any securities of the Company, nor shall it or any part of it or the fact of its
distribution form the basis of, or be relied on in connection with, any contract or commitment thereof. In particular, this
presentation is not intended to be a prospectus or offer document under the applicable laws of any jurisdiction, including India. No
representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy,
completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all
events not current after the date of this presentation. There is no obligation to update, modify or amend this communication or to
otherwise notify the recipient if the information, opinion, projection, forecast or estimate set forth herein, changes or subsequently
becomes inaccurate.
Certain statements contained in this presentation that are not statements of historical fact constitute “forward-looking statements.”
You can generally identify forward looking statements by terminology such as “aim”, “anticipate”, “believe”, “continue”, “could”,
“estimate”, “expect”, “intend”, “may”, “objective”, “goal”, “plan”, “potential”, “project”, “pursue”, “shall”, “should”, “will”, “would”, or
other words or phrases of similar import. These forward-looking statements involve known and unknown risks, uncertainties,
assumptions and other factors that may cause the Company’s actual results, performance or achievements to be materially
different from any future results, performance or achievements expressed or implied by such forward-looking statements or other
projections. Important factors that could cause actual results, performance or achievements to differ materially include, among
others: (a) our ability to successfully implement our strategy, (b) our growth and expansion plans, (c) changes in regulatory norms
applicable to the Company, (d) technological changes, (e) investment income, (f) cash flow projections, and (g) other risks.
This presentation is for general information purposes only, without regard to any specific objectives, financial situations or
informational needs of any particular person. The Company may alter, modify or otherwise change in any manner the content of this
presentation, without obligation to notify any person of such change or changes.
TABLE OF CONTENTS
Industry Landscape
Quarterly and Half Year Highlights
Company Overview
Business Overview
Road Map
Industry Landscape
Insurance Industry Overview
INDIA SRI LANKA MALDIVES KENYA
Recovery and High-growth Digital inclusion
Health-led scale
corporate lines specialist niche tailwinds
12% estimated CAGR 10% estimated CAGR 18% estimated CAGR 15% estimated CAGR
Health 44% | Motor 30% market
Motor-led | Fire & Engineering Tourism | Property | Marine Motor | Medical | Property
share in General Insurance Industry
IRDAI consultation paper | current status
Recalibrating Economics of Insurance Distribution
Regulator’s concerns Broker feedback Consultation read-through IIRM view
• Mis-selling and weak customer • Diagnosis is broadly accepted; the • Extensive engagement across • Some moderation from the original
outcomes remedy must reflect channel insurers, brokers and other proposals is expected
• Insurance penetration and economics stakeholders • Final regulations are still awaited
customer base not expanding • Life and non-life, corporate, retail • Industry responses and media • Implementation date remains
sufficiently and fintech models play different debate have surfaced the practical uncertain
• Distribution costs rising faster than roles nuances • Two plausible effective dates: 1 Jan
premium growth • Uniform principles are possible, • Insurer pushback appears broad, 2027 or 1 Apr 2027
• Need for greater transparency, but identical prescriptions are not except among the largest players
suitability and accountability • Excessive micro-management may likely to gain share
drive opaque or “shadow” • Brokers have also escalated
payments representations across key policy
• Prefer a measured glide path over forums
abrupt structural change • Overall impression: the regulator
now has a fuller view of market
complexity
KEY TAKEAWAY Direction of reform is likely to remain; the key variables are calibration, transition period and implementation date.
Non Life India Insurance Industry Q2 FY27 YoY
Market Share Segment Wise Q2 FY27 Market Share segment wise Q2 FY26
Marine
Marine
2% Engineering
Others Fire 2% Others Fire Engin 2e %ering
15% 6% 15% 9%
Motor
Health 37% Health Motor
38% 36% 36%
% Q2 YoY Growth
% Q1 YoY Growth
32.22% 33.88%
18.73%
14.53% 13.82% 13.90%
12.43% 8.25%
10.04% 9.68%
3.17%
-2.16%
Fire Marine Engineering Motor Health Others Total
-27.84%
-24.57%
Quarterly Highlights
Consolidated Q2 FY27 financial performance in INR Mn
PREMIUM GROWTH Q2 FY27
vs +2% growth in Q2 FY26
REVENUE GROWTH Q2 FY27
vs 24% growth Q2 FY26
EBITDA MARGIN Q2 FY27
300 23%
200 +vs 23% in Q2 FY26
100 67 72
52 52 PAT MARGIN Q2 FY27
Total Income Expenses EBITDA PBT PAT
vs 9% in Q2 FY26
Q2 FY27 Q2 FY26
Management Commentary and Q3 Outlook
Industry Context and Premium
Business Mix and Earnings Resilience
Growth
~8% Overall industry growth +9%
Q2 FY27 premium growth
remains subdued
• Industry growth remains moderate at about 8%. • Lower Property premium rates reduced
reported premium values and headline growth.
• Our Q2 premium growth of 9% is broadly in line
with the market. • Reinsurance and Personal Lines remain strong
growth drivers.
Q3 Stable EBITDA and earnings
Outlook and guidance
performance
• Growth momentum should continue, led by • Improved brokerage yields across most
Reinsurance and Personal Lines. business lines have supported profitability,
• Improved brokerage yields should support while EBITDA has remained stable.
stable earnings.
Consolidated H1 FY27 financial performance in INR Mn
PREMIUM GROWTH H1 FY27
1600
1,416.4 vs +5.2% growth in H1 FY26
1400
1,276.5
REVENUE GROWTH H1 FY27
1200
1,080.8 11%
977.7
1000
vs 12% growth in H1 FY26
EBITDA MARGIN H1 FY27
400 335.6
298.8
+vs 23% in H1 FY26
170.2 175.7
200 129.8 128.6
PAT MARGIN H1 FY27
0 9%
Total Income Expenses EBITDA PBT PAT
H1 FY27 H1 FY26
vs 10% in H1 FY26
Portfolio Spread – Geography wise (Premium)
Premium Location wise (INR Mn.)
GWP mix location wise as on H1 FY27
Maldives
Sri Lanka
16113 2%
13,268 120
11,444
15085
4147
12,785
11,141 34.3
4037 75.7
India
FY24 FY25 FY26 H1 FY27
India Sri Lanka Maldives Total
Portfolio Spread – Line of Business wise(Premium)
GWP LOB wise Mix H1 FY27
SBU wise premium mix as on
[Showing first 8,000 characters — download PDF for full document]